Article (Scientific journals)
Prevention and Management of Donor-transmitted Cancer After Liver Transplantation: Guidelines From the ILTS-SETH Consensus Conference.
Domínguez-Gil, Beatriz; Moench, Kerstin; Watson, Christopher et al.
2022In Transplantation, 106 (1), p. 12-e29
Peer Reviewed verified by ORBi


Full Text
Publisher postprint (234.41 kB)

All documents in ORBi are protected by a user license.

Send to


Keywords :
cancer; transmission; transplantation; graft; complication; risk analysis; tumeur
Abstract :
[en] As with any other intervention in health, liver transplantation (LT) entails a variety of risks, including donor-transmitted cancers (DTCs). At present, 2%-4% of used deceased organ donors are known to have a current or past history of malignancy. The frequency of DTCs is consistently reported at 3-6 cases per 10 000 solid organ transplants, with a similar frequency in the LT setting. A majority of DTCs are occult cancers unknown in the donor at the time of transplantation. Most DTCs are diagnosed within 2 y after LT and are associated with a 51% probability of survival at 2 y following diagnosis. The probability of death is greatest for DTCs that have already metastasized at the time of diagnosis. The International Liver Transplantation Society-Sociedad Española de Trasplante Hepático working group on DTC has provided guidance on how to minimize the occurrence of DTCs while avoiding the unnecessary loss of livers for transplantation both in deceased and living donor LT. The group endorses the Council of Europe classification of risk of transmission of cancer from donor to recipient (minimal, low to intermediate, high, and unacceptable), classifies a range of malignancies in the liver donor into these 4 categories, and recommends when to consider LT, mindful of the risk of DTCs, and the clinical condition of patients on the waiting list. We further provide recommendations to professionals who identify DTC events, stressing the need to immediately alert all stakeholders concerned, so a coordinated investigation and management can be initiated; decisions on retransplantation should be made on a case-by-case basis with a multidisciplinary approach.
Disciplines :
Gastroenterology & hepatology
Author, co-author :
Domínguez-Gil, Beatriz
Moench, Kerstin
Watson, Christopher
Serrano, M. Trinidad
Hibi, Taizo
Asencio, José M.
Van Rosmalen, Marieke
Detry, Olivier  ;  Université de Liège - ULiège > Département des sciences cliniques > Pathologie chirurgicale abdominale et endocrinienne
Heimbach, Julie
Durand, François
Language :
Title :
Prevention and Management of Donor-transmitted Cancer After Liver Transplantation: Guidelines From the ILTS-SETH Consensus Conference.
Publication date :
January 2022
Journal title :
Publisher :
Lippincott Williams & Wilkins, United States - Maryland
Volume :
Issue :
Pages :
Peer reviewed :
Peer Reviewed verified by ORBi
Commentary :
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
Available on ORBi :
since 15 December 2021


Number of views
126 (5 by ULiège)
Number of downloads
66 (3 by ULiège)

Scopus citations®
Scopus citations®
without self-citations


Similar publications

Contact ORBi